7
Views
130
CrossRef citations to date
0
Altmetric
Research Article

The Full Oncogenic Activity of Ret/ptc2 Depends on Tyrosine 539, a Docking Site for Phospholipase Cγ

, , , , , , , , , , & show all
Pages 2151-2163 | Received 25 Sep 1995, Accepted 20 Feb 1996, Published online: 29 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mariantonia Nacchio, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Elena Vigliar, Tommaso Porcelli, Cristina Luongo, Antonino Iaccarino, Fabio Pagni, Domenico Salvatore, Giancarlo Troncone, Umberto Malapelle & Claudio Bellevicine. (2022) Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions. Expert Review of Endocrinology & Metabolism 17:2, pages 167-178.
Read now
Mayumi Jijiwa, Toshifumi Fukuda, Kumi Kawai, Akari Nakamura, Kei Kurokawa, Yoshiki Murakumo, Masatoshi Ichihara & Masahide Takahashi. (2004) A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia. Molecular and Cellular Biology 24:18, pages 8026-8036.
Read now
R. M. Melillo, M. Santoro, S.-H. Ong, M. Billaud, A. Fusco, Y. R. Hadari, J. Schlessinger & I. Lax. (2001) Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade. Molecular and Cellular Biology 21:13, pages 4177-4187.
Read now
Kyle Durick, Gordon N. Gill & Susan S. Taylor. (1998) Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2. Molecular and Cellular Biology 18:4, pages 2298-2308.
Read now

Articles from other publishers (126)

Angelina T. Regua, Mariana Najjar & Hui-Wen Lo. (2022) RET signaling pathway and RET inhibitors in human cancer. Frontiers in Oncology 12.
Crossref
Masahide TAKAHASHI. (2022) RET receptor signaling: Function in development, metabolic disease, and cancer. Proceedings of the Japan Academy, Series B 98:3, pages 112-125.
Crossref
Kyaw Z. Thein, Vamsidhar Velcheti, Blaine H.M. Mooers, Jie Wu & Vivek Subbiah. (2021) Precision therapy for RET-altered cancers with RET inhibitors. Trends in Cancer 7:12, pages 1074-1088.
Crossref
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith & Brendan Frett. (2021) Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development. Journal of Medicinal Chemistry 64:16, pages 11747-11773.
Crossref
Adam Packard, William H. Klein & Frank Costantini. (2021) Ret signaling in ureteric bud epithelial cells controls cell movements, cell clustering and bud formation. Development 148:9.
Crossref
Chang Lu & Qing Zhou. (2021) Diagnostics, therapeutics and RET inhibitor resistance for RET fusion–positive non-small cell lung cancers and future perspectives. Cancer Treatment Reviews 96, pages 102153.
Crossref
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon & Funda Meric-Bernstam. (2020) State-of-the-Art Strategies for Targeting RET -Dependent Cancers . Journal of Clinical Oncology 38:11, pages 1209-1221.
Crossref
Alexander Drilon, Zishuo I. Hu, Gillianne G. Y. Lai & Daniel S. W. Tan. (2017) Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nature Reviews Clinical Oncology 15:3, pages 151-167.
Crossref
Brandy D. Hyndman, Mathieu J. F. Crupi, Susan Peng, Leslie N. Bone, Aisha N. Rekab, Eric Y. Lian, Simona M. Wagner, Costin N. Antonescu & Lois M. Mulligan. (2017) Differential recruitment of E3-ubiquitin ligase complexes regulates RET isoform internalization. Journal of Cell Science.
Crossref
S. Latteyer, L. Klein-Hitpass, C. Khandanpour, D. Zwanziger, T. D. Poeppel, K. W. Schmid, D. Führer, L. C. Moeller & Dagmar Führer-Sakel. (2016) A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A . The Journal of Clinical Endocrinology & Metabolism 101:3, pages 1016-1022.
Crossref
Du-Seock Kang, Yong Ryoul Yang, Cheol Lee, SaetByeol Kim, Sung Ho Ryu & Pann-Ghill Suh. (2016) Roles of phosphoinositide-specific phospholipase Cγ1 in brain development. Advances in Biological Regulation 60, pages 167-173.
Crossref
Gilbert J. Cote, Rozita Bagheri-Yarmand, Marie-Claude Hofmann & Robert F. Gagel. 2016. Medullary Thyroid Cancer. Medullary Thyroid Cancer 47 63 .
M Curcio, I L Salazar, A R Inácio, E P Duarte, L M T Canzoniero & C B Duarte. (2015) Brain ischemia downregulates the neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons. Cell Death & Disease 6:2, pages e1645-e1645.
Crossref
Gilbert J. Cote, Elizabeth G. Grubbs & Marie-Claude Hofmann. 2015. Medullary Thyroid Carcinoma. Medullary Thyroid Carcinoma 1 39 .
Maria Domenica Castellone & Giancarlo Vecchio. 2015. Chromosomal Translocations and Genome Rearrangements in Cancer. Chromosomal Translocations and Genome Rearrangements in Cancer 357 380 .
Rosa Marina Melillo & Massimo Santoro. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. Receptor Tyrosine Kinases: Family and Subfamilies 559 591 .
I. Plaza-Menacho, L. Mologni & N.Q. McDonald. (2014) Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy. Cellular Signalling 26:8, pages 1743-1752.
Crossref
Lois M. Mulligan. (2014) RET revisited: expanding the oncogenic portfolio. Nature Reviews Cancer 14:3, pages 173-186.
Crossref
Y Luo, K D Tsuchiya, D Il Park, R Fausel, S Kanngurn, P Welcsh, S Dzieciatkowski, J Wang & W M Grady. (2012) RET is a potential tumor suppressor gene in colorectal cancer. Oncogene 32:16, pages 2037-2047.
Crossref
Shilpa Ramaswamy & Jeffrey H. Kordower. (2012) Gene therapy for Huntington's disease. Neurobiology of Disease 48:2, pages 243-254.
Crossref
Evita M. Lindholm, Alexandr Kristian, Hawa Nalwoga, Kristi Krüger, Ståle Nygård, Lars A. Akslen, Gunhild M. Maelandsmo & Olav Engebraaten. (2012) Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. Molecular Oncology 6:4, pages 418-427.
Crossref
Daniela Molè, Erica Gentilin, Teresa Gagliano, Federico Tagliati, Marta Bondanelli, Maria Rosa Pelizzo, Martina Rossi, Carlo Filieri, Giancarlo Pansini, Ettore C. degli Uberti & Maria Chiara Zatelli. (2012) Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro. Endocrinology 153:5, pages 2088-2098.
Crossref
T. Kalle Lundgren, Katsutoshi Nakahata, Nicolas Fritz, Paola Rebellato, Songbai Zhang & Per Uhlén. (2012) RET PLCγ Phosphotyrosine Binding Domain Regulates Ca2+ Signaling and Neocortical Neuronal Migration. PLoS ONE 7:2, pages e31258.
Crossref
Regina Willecke, Julian Heuberger, Katja Grossmann, Odyssé Michos, Kai Schmidt-Ott, Katharina Walentin, Frank Costantini & Walter Birchmeier. (2011) The tyrosine phosphatase Shp2 acts downstream of GDNF/Ret in branching morphogenesis of the developing mouse kidney. Developmental Biology 360:2, pages 310-317.
Crossref
Maria Rosaria SapioAnna GuerraVincenzo MarottaElisabetta CampanileRaffaele FormisanoMaurilio DeandreaManuela MottaPaolo Piero LimoneGianfranco FenziGuido RossiMario Vitale. (2011) High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements. The Journal of Clinical Endocrinology & Metabolism 96:6, pages E916-E919.
Crossref
Brian S Schmutzler, Shannon Roy, Sherry K Pittman, Rena M Meadows & Cynthia M Hingtgen. (2011) Ret-Dependent and Ret-Independent Mechanisms of Gfl-Induced Sensitization. Molecular Pain 7, pages 1744-8069-7-22.
Crossref
Suresh Babu Rangasamy, Katherine Soderstrom, Roy A.E. Bakay & Jeffrey H. Kordower. 2010. Recent Advances in Parkinson’S Disease - Translational and Clinical Research. Recent Advances in Parkinson’S Disease - Translational and Clinical Research 237 264 .
Amber L. Traugott & Jeffrey F. Moley. 2010. Endocrine Neoplasia. Endocrine Neoplasia 303 319 .
Samuel A. WellsJr.Jr. & Massimo Santoro. (2009) Targeting the RET Pathway in Thyroid Cancer . Clinical Cancer Research 15:23, pages 7119-7123.
Crossref
Shilpa Ramaswamy & Jeffrey H. Kordower. (2009) Are growth factors the answer?. Parkinsonism & Related Disorders 15, pages S176-S180.
Crossref
Elizabete Rosária de Miranda, Luiz De Marco & Maria Marta Sarquis Soares. (2009) Splicing variants impact in thyroid normal physiology and pathological conditions. Arquivos Brasileiros de Endocrinologia & Metabologia 53:6, pages 709-715.
Crossref
L. Gorla, P. Mondellini, G. Cuccuru, F. Miccichè, G. Cassinelli, M. Cremona, M.A. Pierotti, C. Lanzi & I. Bongarzone. (2009) Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: Identification of new signaling elements. Molecular Carcinogenesis 48:3, pages 220-231.
Crossref
Silvia Stacchiotti, Elena Tamborini, Andrea Marrari, Silvia Brich, Sara Arisi Rota, Marta Orsenigo, Flavio Crippa, Carlo Morosi, Alessandro Gronchi, Marco A. Pierotti, Paolo G. Casali & Silvana Pilotti. (2009) Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma. Clinical Cancer Research 15:3, pages 1096-1104.
Crossref
Mi-Young KangKweon Young KimYoung YoonYoonsung KangHong Beum KimCha Kyung YounDong-Hui KimMi-Hwa Kim. (2009) Ape1/Ref-1 Stimulates GDNF/GFRα1-mediated Downstream Signaling and Neuroblastoma Proliferation. The Korean Journal of Physiology and Pharmacology 13:5, pages 349.
Crossref
Giuliana Cassinelli, Enrica Favini, Debora Degl'Innocenti, Alessandro Salvi, Giuseppina De Petro, Marco A. Pierotti, Franco Zunino, Maria Grazia Borrello & Cinzia Lanzi. (2009) RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation. Neoplasia 11:1, pages 10-21.
Crossref
Maria Domenica Castellone & Massimo Santoro. (2008) Dysregulated RET Signaling in Thyroid Cancer. Endocrinology and Metabolism Clinics of North America 37:2, pages 363-374.
Crossref
Ryozo Tsuji, Vittorio Fattori, Shin-ichi Abe, Lucio G. Costa & Kumiko Kobayashi. (2008) Effects of postnatal ethanol exposure at different developmental phases on neurotrophic factors and phosphorylated proteins on signal transductions in rat brain. Neurotoxicology and Teratology 30:3, pages 228-236.
Crossref
Volkert B. Wreesmann & Bhuvanesh Singh. (2008) Clinical Impact of Molecular Analysis on Thyroid Cancer Management. Surgical Oncology Clinics of North America 17:1, pages 1-35.
Crossref
Stefania Mariggiò, Beatrice Maria Filippi, Cristiano Iurisci, Luana Katia Dragani, Valentina De Falco, Massimo Santoro & Daniela Corda. (2007) Cytosolic Phospholipase A2α Regulates Cell Growth in RET/PTC -Transformed Thyroid Cells . Cancer Research 67:24, pages 11769-11778.
Crossref
S Donatello, A Fiorino, D Degl'Innocenti, L Alberti, C Miranda, L Gorla, I Bongarzone, M G Rizzetti, M A Pierotti & M G Borrello. (2007) SH2B1β adaptor is a key enhancer of RET tyrosine kinase signaling. Oncogene 26:45, pages 6546-6559.
Crossref
Jason A. Gustin, Mao Yang, Eugene M. Johnson & Jeffrey Milbrandt. (2007) Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth. Journal of Neurochemistry 102:4, pages 1184-1194.
Crossref
Maki Ishida, Masatoshi Ichihara, Shinji Mii, Mayumi Jijiwa, Naoya Asai, Atsushi Enomoto, Takuya Kato, Ai Majima, Jiang Ping, Yoshiki Murakumo & Masahide Takahashi. (2007) Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase. Cancer Science 98:6, pages 815-821.
Crossref
Brian A. Pierchala, Cynthia C. Tsui, Jeffrey Milbrandt & Eugene M. Johnson. (2007) NGF augments the autophosphorylation of Ret via inhibition of ubiquitin-dependent degradation. Journal of Neurochemistry 100:5, pages 1169-1176.
Crossref
Tiziano Tuccinardi, Fabrizio Manetti, Silvia Schenone, Adriano Martinelli & Maurizio Botta. (2007) Construction and Validation of a RET TK Catalytic Domain by Homology Modeling. Journal of Chemical Information and Modeling 47:2, pages 644-655.
Crossref
L. Gorla, M. Cantù, F. Miccichè, C. Patelli, P. Mondellini, M.A. Pierotti & I. Bongarzone. (2006) RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism. Cellular Signalling 18:12, pages 2272-2282.
Crossref
Chandan Kumar-Sinha, Scott A. Tomlins & Arul M. Chinnaiyan. (2006) Evidence of recurrent gene fusions in common epithelial tumors. Trends in Molecular Medicine 12:11, pages 529-536.
Crossref
Aaron N. Cranston, Cristiana Carniti, Kim Oakhill, Elzbieta Radzio-Andzelm, Eric A. Stone, Andrew S. McCallion, Shirley Hodgson, Sue Clarke, Piera Mondellini, Jean Leyland, Marco A. Pierotti, Joanne Whittaker, Susan S. Taylor, Italia Bongarzone & Bruce A.J. Ponder. (2006) RET Is Constitutively Activated by Novel Tandem Mutations that Alter the Active Site Resulting in Multiple Endocrine Neoplasia Type 2B. Cancer Research 66:20, pages 10179-10187.
Crossref
T. Kalle Lundgren, Rizaldy P. Scott, Matthew Smith, Tony Pawson & Patrik Ernfors. (2006) Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival. Journal of Biological Chemistry 281:40, pages 29886-29896.
Crossref
Matthias Drosten & Brigitte M Pützer. (2006) Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nature Clinical Practice Oncology 3:10, pages 564-574.
Crossref
Yoshiki Murakumo, Mayumi Jijiwa, Naoya Asai, Masatoshi Ichihara & Masahide Takahashi. (2006) RET and neuroendocrine tumors. Pituitary 9:3, pages 179-192.
Crossref
Jan Willem B. de GrootThera P. LinksJohn T. M. PlukkerCornelis J. M. Lips & Robert M. W. Hofstra. (2006) RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors. Endocrine Reviews 27:5, pages 535-560.
Crossref
Yong Zhang, Wei Zhu, Yong-Gang Wang, Xiu-Jie Liu, Li Jiao, Xuan Liu, Zhao-Huan Zhang, Chang-Lin Lu & Cheng He. (2006) Interaction of SH2-Bβ with RET is involved in signaling of GDNF-induced neurite outgrowth. Journal of Cell Science 119:8, pages 1666-1676.
Crossref
Carlo Iavarone, Mario Acunzo, Francesca Carlomagno, Annunziata Catania, Rosa M. Melillo, Stella M. Carlomagno, Massimo Santoro & Mario Chiariello. (2006) Activation of the Erk8 Mitogen-activated Protein (MAP) Kinase by RET/PTC3, a Constitutively Active Form of the RET Proto-oncogene. Journal of Biological Chemistry 281:15, pages 10567-10576.
Crossref
H. Peterziel & J. Strelau. 2006. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology 69 91 .
Rebecca Hui Kwan Lee, Wai Lap Wong, Chin Ho Chan & Siu Yuen Chan. (2006) Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRα1-expressing cells. Journal of Neuroscience Research 83:1, pages 80-90.
Crossref
Renee D Read, Paul J Goodfellow, Elaine R Mardis, Nancy Novak, Jon R Armstrong & Ross L Cagan. (2005) A Drosophila Model of Multiple Endocrine Neoplasia Type 2. Genetics 171:3, pages 1057-1081.
Crossref
Ganesh R. Panta, Lihua Du, Fiemu E. Nwariaku & Lawrence T. Kim. (2005) Direct phosphorylation of proliferative and survival pathway proteins by RET. Surgery 138:2, pages 269-274.
Crossref
Elena Arighi, Maria Grazia Borrello & Hannu Sariola. (2005) RET tyrosine kinase signaling in development and cancer. Cytokine & Growth Factor Reviews 16:4-5, pages 441-467.
Crossref
Toshifumi Fukuda, Naoya Asai, Atsushi Enomoto & Masahide Takahashi. (2005) Activation of c-Jun amino-terminal kinase by GDNF induces G2/M cell cycle delay linked with actin reorganization. Genes to Cells 10:7, pages 655-663.
Crossref
Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco & Massimo Santoro. (2005) The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. Journal of Clinical Investigation 115:4, pages 1068-1081.
Crossref
Ivan Plaza Menacho, Roelof Koster, Almer M. van der Sloot, Wim J. Quax, Jan Osinga, Tineke van der Sluis, Harry Hollema, Grzegorz M. Burzynski, Oliver Gimm, Charles H.C.M. Buys, Bart J.L. Eggen & Robert M.W. Hofstra. (2005) RET-Familial Medullary Thyroid Carcinoma Mutants Y791F and S891A Activate a Src/JAK/STAT3 Pathway, Independent of Glial Cell Line–Derived Neurotrophic Factor. Cancer Research 65:5, pages 1729-1737.
Crossref
Hideki Enomoto. (2005) Regulation of neural development by glial cell line-derived neurotrophic factor family ligands. Anatomical Science International 80:1, pages 42-52.
Crossref
Yoshinori Kodama, Naoya Asai, Kumi Kawai, Mayumi Jijiwa, Yoshiki Murakumo, Masatoshi Ichihara & Masahide Takahashi. (2005) The RET proto-oncogene: A molecular therapeutic target in thyroid cancer. Cancer Science 96:3, pages 143-148.
Crossref
Marco A. Pierotti, Elena Arighi, Debora Degl’innocenti & Maria Grazia Borrello. 2005. Molecular Basis of Thyroid Cancer. Molecular Basis of Thyroid Cancer 389 415 .
Gunnar Schuetz, Marta Rosário, Jan Grimm, Tobias M. Boeckers, Eckart D. Gundelfinger & Walter Birchmeier. (2004) The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. Journal of Cell Biology 167:5, pages 945-952.
Crossref
Eun Suk Hwang, Dong Wook Kim, Jung Hwan Hwang, Hye Sook Jung, Jae Mi Suh, Young Joo Park, Hyo Kyun Chung, Jung Hun Song, Ki Cheol Park, Su Hyeon Park, Hwan-Jung Yun, Jin Man Kim & Minho Shong. (2004) Regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT1-Dependent Genes by RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Oncogenic Tyrosine Kinases. Molecular Endocrinology 18:11, pages 2672-2684.
Crossref
Derek K. Marsee, Anjli Venkateswaran, Haiyang Tao, Douangsone Vadysirisack, Zhaoxia Zhang, Dale D. Vandre & Sissy M. Jhiang. (2004) Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells. Journal of Biological Chemistry 279:42, pages 43990-43997.
Crossref
Robert J. Crowder, Hideki Enomoto, Mao Yang, Eugene M. JohnsonJr.Jr. & Jeffrey Milbrandt. (2004) Dok-6, a Novel p62 Dok Family Member, Promotes Ret-mediated Neurite Outgrowth. Journal of Biological Chemistry 279:40, pages 42072-42081.
Crossref
Kengo Maeda, Hideki Murakami, Reiko Yoshida, Masatoshi Ichihara, Akihiro Abe, Makoto Hirai, Toyoaki Murohara & Masahide Takahashi. (2004) Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells. Biochemical and Biophysical Research Communications 323:1, pages 345-354.
Crossref
Debora Degl'Innocenti, Elena Arighi, Anna Popsueva, Romina Sangregorio, Luisella Alberti, Maria Grazia Rizzetti, Cristina Ferrario, Hannu Sariola, Marco A Pierotti & Maria Grazia Borrello. (2004) Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching. Oncogene 23:44, pages 7297-7309.
Crossref
G. Cuccuru, C. Lanzi, G. Cassinelli, G. Pratesi, M. Tortoreto, G. Petrangolini, E. Seregni, A. Martinetti, D. Laccabue, C. Zanchi & F. Zunino. (2004) Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma. JNCI Journal of the National Cancer Institute 96:13, pages 1006-1014.
Crossref
Shirley M. Myers & Lois M. Mulligan. (2004) The RET Receptor Is Linked to Stress Response Pathways. Cancer Research 64:13, pages 4453-4463.
Crossref
Brigitte M. Pützer & Matthias Drosten. (2004) The RET proto-oncogene: a potential target for molecular cancer therapy. Trends in Molecular Medicine 10:7, pages 351-357.
Crossref
John P. Russell, Julie B. Engiles & Jay L. Rothstein. (2004) Proinflammatory Mediators and Genetic Background in Oncogene Mediated Tumor Progression. The Journal of Immunology 172:7, pages 4059-4067.
Crossref
Mario Encinas, Robert J. Crowder, Jeffrey Milbrandt & Eugene M. JohnsonJr.Jr.. (2004) Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival. Journal of Biological Chemistry 279:18, pages 18262-18269.
Crossref
Yoshiyuki Kawamoto, Kozue Takeda, Yusuke Okuno, Yoshinori Yamakawa, Yasutomo Ito, Ryo Taguchi, Masashi Kato, Haruhiko Suzuki, Masahide Takahashi & Izumi Nakashima. (2004) Identification of RET Autophosphorylation Sites by Mass Spectrometry. Journal of Biological Chemistry 279:14, pages 14213-14224.
Crossref
Maria Domenica Castellone, Angela Celetti, Valentina Guarino, Anna Maria Cirafici, Fulvio Basolo, Riccardo Giannini, Enzo Medico, Mogens Kruhoffer, Torben F Orntoft, Francesco Curcio, Alfredo Fusco, Rosa Marina Melillo & Massimo Santoro. (2004) Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. Oncogene 23:12, pages 2188-2196.
Crossref
Efisio Puxeddu, Norisato Mitsutake, Jeffrey A. Knauf, Sonia Moretti, Hei W. Kim, Karen A. Seta, Diane Brockman, Leslie Myatt, David E. Millhorn & James A. Fagin. (2003) Microsomal Prostaglandin E2 Synthase-1 Is Induced by Conditional Expression of RET/PTC in Thyroid PCCL3 Cells through the Activation of the MEK-ERK Pathway. Journal of Biological Chemistry 278:52, pages 52131-52138.
Crossref
M. DrostenT. StieweB.M. Pützer. (2003) Antitumor Capacity of a Dominant-Negative RET Proto-Oncogene Mutant in a Medullary Thyroid Carcinoma Model . Human Gene Therapy 14:10, pages 971-982.
Crossref
Jeffrey A Knauf, Hiroaki Kuroda, Saswata Basu & James A Fagin. (2003) RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase. Oncogene 22:28, pages 4406-4412.
Crossref
Dong Wook Kim, Jung Hwan Hwang, Jae Mi Suh, Ho Kim, Jung Hun Song, Eun Suk Hwang, Il Young Hwang, Ki Cheol Park, Hyo Kyun Chung, Jin Man Kim, Jongsun Park, Brian A. Hemmings & Minho Shong. (2003) RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinomas) Tyrosine Kinase Phosphorylates and Activates Phosphoinositide-Dependent Kinase 1 (PDK1): An Alternative Phosphatidylinositol 3-Kinase-Independent Pathway to Activate PDK1. Molecular Endocrinology 17:7, pages 1382-1394.
Crossref
Jung Hwan Hwang, Dong Wook Kim, Jae Mi Suh, Ho Kim, Jung Hun Song, Eun Suk Hwang, Ki Cheol Park, Hyo Kyun Chung, Jin Man Kim, Tae-Hoon Lee, Dae-Yeul Yu & Minho Shong. (2003) Activation of Signal Transducer and Activator of Transcription 3 by Oncogenic RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Tyrosine Kinase: Roles in Specific Gene Regulation and Cellular Transformation. Molecular Endocrinology 17:6, pages 1155-1166.
Crossref
K Kurokawa, K. Kawai, M. Hashimoto, Y. Ito & M. Takahashi. (2003) Cell signalling and gene expression mediated by RET tyrosine kinase. Journal of Internal Medicine 253:6, pages 627-633.
Crossref
Francesco Andreozzi, Rosa Marina Melillo, Francesca Carlomagno, Francesco Oriente, Claudia Miele, Francesca Fiory, Stefania Santopietro, Maria Domenica Castellone, Francesco Beguinot, Massimo Santoro & Pietro Formisano. (2003) Protein kinase Cα activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. Oncogene 22:19, pages 2942-2949.
Crossref
Maria Domenica Castellone, Anna Maria Cirafici, Gabriella De Vita, Valentina De Falco, Luca Malorni, Giovanni Tallini, James A Fagin, Alfredo Fusco, Rosa Marina Melillo & Massimo Santoro. (2003) Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. Oncogene 22:2, pages 246-255.
Crossref
Minerva M. Carrasquillo, Andrew S. McCallion, Erik G. Puffenberger, Carl S. Kashuk, Nassim Nouri & Aravinda Chakravarti. (2002) Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nature Genetics 32:2, pages 237-244.
Crossref
Brian A. Tsui-Pierchala, Rebecca C. Ahrens, Robert J. Crowder, Jeffrey Milbrandt & Eugene M. JohnsonJr.Jr.. (2002) The Long and Short Isoforms of Ret Function as Independent Signaling Complexes. Journal of Biological Chemistry 277:37, pages 34618-34625.
Crossref
Hideki Murakami, Yumiko Yamamura, Yohei Shimono, Kumi Kawai, Kei Kurokawa & Masahide Takahashi. (2002) Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase. Journal of Biological Chemistry 277:36, pages 32781-32790.
Crossref
Maria Grazia Borrello, Elena Mercalli, Carla Perego, Debora Degl'Innocenti, Simona Ghizzoni, Elena Arighi, Barbara Eroini, Maria Grazia Rizzetti & Marco A Pierotti. (2002) Differential interaction of Enigma protein with the two RET isoforms. Biochemical and Biophysical Research Communications 296:3, pages 515-522.
Crossref
Naoko Iwahashi, Hideki Murakami, Yuji Nimura & Masahide Takahashi. (2002) Activation of RET tyrosine kinase regulates interleukin-8 production by multiple signaling pathways. Biochemical and Biophysical Research Communications 294:3, pages 642-649.
Crossref
Toshifumi Fukuda, Kazutoshi Kiuchi & Masahide Takahashi. (2002) Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase. Journal of Biological Chemistry 277:21, pages 19114-19121.
Crossref
Ming-Jer Tang, Yi Cai, Si-Jie Tsai, Yang-Kao Wang & Gregory R. Dressler. (2002) Ureteric Bud Outgrowth in Response to RET Activation Is Mediated by Phosphatidylinositol 3-Kinase. Developmental Biology 243:1, pages 128-136.
Crossref
Muriel Coulpier, Jonas Anders & Carlos F. Ibáñez. (2002) Coordinated Activation of Autophosphorylation Sites in the RET Receptor Tyrosine Kinase. Journal of Biological Chemistry 277:3, pages 1991-1999.
Crossref
Jodi L. McBride & Jeffrey H. Kordower. 2002. Plasticity in the Adult Brain: From Genes to Neurotherapy. Plasticity in the Adult Brain: From Genes to Neurotherapy 421 432 .
Masahide Takahashi. (2001) The GDNF/RET signaling pathway and human diseases. Cytokine & Growth Factor Reviews 12:4, pages 361-373.
Crossref
Giovanni Tallini, Sylvia L. Asa & Gregory N. Fuller. (2001) RET Oncogene Activation in Papillary Thyroid Carcinoma. Advances in Anatomic Pathology 8:6, pages 345-354.
Crossref
Maria Vittoria Barone, Leandra Sepe, Rosa Marina Melillo, Alba Mineo, Giovanni Santelli, Carmen Monaco, Maria Domenica Castellone, Donatella Tramontano, Alfredo Fusco & Massimo Santoro. (2001) RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Oncogene 20:48, pages 6973-6982.
Crossref
Jan Jacob Schuringa, Katarzyna Wojtachnio, Werner Hagens, Edo Vellenga, Charles HCM Buys, Robert Hofstra & Wiebe Kruijer. (2001) MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 20:38, pages 5350-5358.
Crossref
Jan Grimm, Martin Sachs, Stefan Britsch, Silvana Di Cesare, Thomas Schwarz-Romond, Kari Alitalo & Walter Birchmeier. (2001) Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. Journal of Cell Biology 154:2, pages 345-354.
Crossref
Elena Mercalli, Simona Ghizzoni, Elena Arighi, Luisella Alberti, Romina Sangregorio, Maria T Radice, Mikhail L Gishizky, Marco A Pierotti & Maria Grazia Borrello. (2001) Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein. Oncogene 20:27, pages 3475-3485.
Crossref
Atsushi Natsume, Marina Mata, James Goss, Shaohua Huang, Darren Wolfe, Thomas Oligino, Joseph Glorioso & David J. Fink. (2001) Bcl-2 and GDNF Delivered by HSV-Mediated Gene Transfer Act Additively to Protect Dopaminergic Neurons from 6-OHDA-Induced Degeneration. Experimental Neurology 169:2, pages 231-238.
Crossref
Shanlou Qiao, Toshihide Iwashita, Tatsuhiko Furukawa, Masahiko Yamamoto, Gen Sobue & Masahide Takahashi. (2001) Differential Effects of Leukocyte Common Antigen-related Protein on Biochemical and Biological Activities of RET-MEN2A and RET-MEN2B Mutant Proteins. Journal of Biological Chemistry 276:12, pages 9460-9467.
Crossref
Yasuhito Hayashi, Toshihide Iwashita, Hideki Murakamai, Yutaka Kato, Kumi Kawai, Kei Kurokawa, Iwai Tohnai, Minoru Ueda & Masahide Takahashi. (2001) Activation of BMK1 via Tyrosine 1062 in RET by GDNF and MEN2A Mutation. Biochemical and Biophysical Research Communications 281:3, pages 682-689.
Crossref
Rosa Marina Melillo, Francesca Carlomagno, Gabriella De Vita, Pietro Formisano, Giancarlo Vecchio, Alfredo Fusco, Marc Billaud & Massimo Santoro. (2001) The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. Oncogene 20:2, pages 209-218.
Crossref
Thomas J. Musholt, Petra B. Musholt, Nawid Khaladj, Daniela Schulz, Georg F.W. Scheumann & Juergen Klempnauer. (2000) Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 128:6, pages 984-993.
Crossref
Sissy M Jhiang. (2000) The RET proto-oncogene in human cancers. Oncogene 19:49, pages 5590-5597.
Crossref
Hironori Hayashi, Masatoshi Ichihara, Toshihide Iwashita, Hideki Murakami, Yohei Shimono, Kumi Kawai, Kei Kurokawa, Yoshiki Murakumo, Tsuneo Imai, Hiroomi Funahashi, Akimasa Nakao & Masahide Takahashi. (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19:39, pages 4469-4475.
Crossref
D H Arlt, B Baur, B Wagner & W Höppner. (2000) A novel type of mutation in the cysteine rich domain of the RET receptor causes ligand independent activation. Oncogene 19:30, pages 3445-3448.
Crossref
Giuliana Cassinelli, Cinzia Lanzi, Tiziana Pensa, Romolo A Gambetta, Gianluca Nasini, Giuditta Cuccuru, Marco Cassinis, Graziella Pratesi, Donatella Polizzi, Monica Tortoreto & Franco Zunino. (2000) Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin. Biochemical Pharmacology 59:12, pages 1539-1547.
Crossref
Carine Segouffin-Cariou & Marc Billaud. (2000) Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway. Journal of Biological Chemistry 275:5, pages 3568-3576.
Crossref
Cinzia Lanzi, Giuliana Cassinelli, Tiziana Pensa, Marco Cassinis, Romolo A. Gambetta, Maria G. Borrello, Ernesto Menta, Marco A. Pierotti & Franco Zunino. (2000) Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative. International Journal of Cancer 85:3, pages 384-390.
Crossref
Graham Carpenter & Qun-sheng Ji. (1999) Phospholipase C-γ as a Signal-Transducing Element. Experimental Cell Research 253:1, pages 15-24.
Crossref
Robert E. McAlhany, Rajesh C. Miranda, Richard H. Finnell & James R. West. (1999) Ethanol Decreases Glial Derived Neurotrophic Factor (GDNF) Protein Release but Not mRNA Expression and Increases GDNF-Stimulated Shc Phosphorylation in the Developing Cerebellum. Alcoholism: Clinical and Experimental Research 23:10, pages 1691-1697.
Crossref
Ansuman Chattopadhyay, Manuela Vecchi, Qun-sheng Ji, Raymond Mernaugh & Graham Carpenter. (1999) The Role of Individual SH2 Domains in Mediating Association of Phospholipase C-γ1 with the Activated EGF Receptor. Journal of Biological Chemistry 274:37, pages 26091-26097.
Crossref
Italia Bongarzone, Elena Vigano, Luisella Alberti, Piera Mondellini, Mauro Uggeri, Barbara Pasini, Maria Grazia Borrello & Marco A Pierotti. (1999) The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. Oncogene 18:34, pages 4833-4838.
Crossref
Pierre Aman. (1999) Fusion genes in solid tumors. Seminars in Cancer Biology 9:4, pages 303-318.
Crossref
Hideki Murakami, Toshihide Iwashita, Naoya Asai, Yohei Shimono, Yosuke Iwata, Kumi Kawai & Masahide Takahashi. (1999) Enhanced Phosphatidylinositol 3-Kinase Activity and High Phosphorylation State of Its Downstream Signalling Molecules Mediated by Ret with the MEN 2B Mutation. Biochemical and Biophysical Research Communications 262:1, pages 68-75.
Crossref
Miles Trupp, Rizaldy Scott, Scott R. Whittemore & Carlos F. Ibáñez. (1999) Ret-dependent and -independent Mechanisms of Glial Cell Line-derived Neurotrophic Factor Signaling in Neuronal Cells. Journal of Biological Chemistry 274:30, pages 20885-20894.
Crossref
Matti S. Airaksinen, Alexey Titievsky & Mart Saarma. (1999) GDNF Family Neurotrophic Factor Signaling: Four Masters, One Servant?. Molecular and Cellular Neuroscience 13:5, pages 313-325.
Crossref
Amanda Capes-Davis & Bruce G. Robinson. (1999) Return of the native: deducing the normal function of the RET proto-oncogene. Current Opinion in Endocrinology & Diabetes 6:1, pages 61.
Crossref
Andrew H. Fischer, Jane A. Bond, Panya Taysavang, O. Eugene Battles & David Wynford-Thomas. (1998) Papillary Thyroid Carcinoma Oncogene (RET/PTC) Alters the Nuclear Envelope and Chromatin Structure. The American Journal of Pathology 153:5, pages 1443-1450.
Crossref
Ming-Jer Tang, Dane Worley, Michele Sanicola & Gregory R. Dressler. (1998) The RET–Glial Cell-derived Neurotrophic Factor (GDNF) Pathway Stimulates Migration and Chemoattraction of Epithelial Cells. Journal of Cell Biology 142:5, pages 1337-1345.
Crossref
Shunhua Xing, Tara L. Furminger, Qiang Tong & Sissy M. Jhiang. (1998) Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma Cells. Journal of Biological Chemistry 273:9, pages 4909-4914.
Crossref
D. H. J. van Weering & J. L. Bos. 1998. Genes and Environment in Cancer. Genes and Environment in Cancer 271 281 .
S. M. Jhiang, J.-Y. Cho, T. L. Furminger, J. E. Sagartz, Q. Tong, C. C. Capen & E. L. Mazzaferri. 1998. Genes and Environment in Cancer. Genes and Environment in Cancer 265 270 .
Robin Hesketh. 1997. The Oncogene & Tumour Suppressor Gene Factsbook. The Oncogene & Tumour Suppressor Gene Factsbook 341 349 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.